STOCKWATCH
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly ResultMay 12, 2026, 04:13 PM

Electromed Q3 Revenue +18.4% to $18.6M; Net Income +58.8%

AI Summary

Electromed, Inc. announced record financial results for the third quarter ended March 31, 2026, with net revenues increasing 18.4% to $18.6 million and net income rising 58.8% to $3.0 million. The company also reported a significant 76.0% increase in operating income to $3.8 million, driven by strong performance in its core homecare market. Additionally, Electromed updated its investor presentation for upcoming meetings with investors and analysts.

Key Highlights

  • Net revenues increased 18.4% to a record $18.6 million in Q3 FY2026.
  • Operating income surged 76.0% to a record $3.8 million, representing 20.3% of net revenues.
  • Net income grew 58.8% to a record $3.0 million, or $0.35 per diluted share.
  • Gross profit increased to $14.6 million, with a gross margin of 78.8%.
  • Direct homecare revenue rose 18.6% to $16.7 million, driven by increased sales productivity.
  • The company ended the quarter with $17.0 million in cash and no debt.
  • Electromed updated its investor presentation for meetings with investors and analysts.
ELMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Electromed, Inc.

Price Impact